Synthesis, inhibition effects, molecular docking and theoretical studies as Paraoxonase 1 (PON1) inhibitors of novel 1,4-dihydropyridine substituted sulfonamide derivatives
dc.contributor.author | Kaya, Mustafa Oguzhan | |
dc.contributor.author | Demirci, Tuna | |
dc.contributor.author | Özdemir, Oğuzhan | |
dc.contributor.author | Çalışır, Ümit | |
dc.contributor.author | Sönmez, Fatih | |
dc.contributor.author | Arslan, Mustafa | |
dc.date.accessioned | 2023-07-26T11:51:10Z | |
dc.date.available | 2023-07-26T11:51:10Z | |
dc.date.issued | 2023 | |
dc.department | DÜ, Rektörlük, Bilimsel ve Teknolojik Araştırmalar Uygulama ve Araştırma Merkezi | en_US |
dc.description.abstract | The novel sulfonamide substitute 1,4-dihydropyridine derivatives were synthesized by the method of Hantzsch reaction. They have been characterized by FT-IR spectroscopy, H-1-NMR, C-13-NMR, and elemental analysis. PON1 which is an antioxidant enzyme has important functions in cardiovascular systems. The enzyme has been purified using a two-step method such as ammonium sulfate precipitation and sepharose-4B-l-tyrosine-9-aminophenanthrene hydrophobic interaction chromatography. The results demonstrated that all the synthesized compounds inhibited PON1 enzyme. The best inhibition effect was observed in compound (1) for PON1 enzyme (IC50: 8.04 mu M, K-i: 5.43 mu M). The free radical scavenging for PON1 was discovered as 20.16 mg/mL, while drug score value was reported as 0.13 for compound (1). Furthermore, the lowest binding energy (-1.31 kcal/mol) determined by molecular docking for PON1 enzyme and the lowest LUMO-HOMO gap ( increment E = 3.12 eV) were calculated for compound (1). | en_US |
dc.identifier.doi | 10.1007/s00044-023-03029-7 | |
dc.identifier.issn | 1054-2523 | |
dc.identifier.issn | 1554-8120 | |
dc.identifier.scopus | 2-s2.0-85149012757 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s00044-023-03029-7 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/12507 | |
dc.identifier.wos | WOS:000942171600003 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.institutionauthor | Demirci, Tuna | |
dc.language.iso | en | en_US |
dc.publisher | Springer Birkhauser | en_US |
dc.relation.ispartof | Medicinal Chemistry Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | $2023V1Guncelleme$ | en_US |
dc.subject | Pon1; Inhibition; Drug Score; Molecular Docking; 1; 4-Dihydropyridine | en_US |
dc.subject | Pharmacological-Activities; Drug Discovery; Purification | en_US |
dc.title | Synthesis, inhibition effects, molecular docking and theoretical studies as Paraoxonase 1 (PON1) inhibitors of novel 1,4-dihydropyridine substituted sulfonamide derivatives | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 12507.pdf
- Boyut:
- 1.62 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text